19 reports of this reaction
21.6% of all POTASSIUM CHLORIDE FOR ORAL SOLUTION reports
#1 most reported adverse reaction
COMPLETED SUICIDE is the #1 most commonly reported adverse reaction for POTASSIUM CHLORIDE FOR ORAL SOLUTION, manufactured by Ajenat Pharmaceuticals LLC. There are 19 FDA adverse event reports linking POTASSIUM CHLORIDE FOR ORAL SOLUTION to COMPLETED SUICIDE. This represents approximately 21.6% of all 88 adverse event reports for this drug.
Patients taking POTASSIUM CHLORIDE FOR ORAL SOLUTION who experience completed suicide should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COMPLETED SUICIDE is a frequently reported adverse event for POTASSIUM CHLORIDE FOR ORAL SOLUTION, accounting for a significant proportion of all reports.
In addition to completed suicide, the following adverse reactions have been reported for POTASSIUM CHLORIDE FOR ORAL SOLUTION:
The following drugs have also been linked to completed suicide in FDA adverse event reports:
COMPLETED SUICIDE has been reported as an adverse event in 19 FDA reports for POTASSIUM CHLORIDE FOR ORAL SOLUTION. This does not prove causation, but indicates an association observed in post-market surveillance data.
COMPLETED SUICIDE accounts for approximately 21.6% of all adverse event reports for POTASSIUM CHLORIDE FOR ORAL SOLUTION, making it one of the most commonly reported side effect.
If you experience completed suicide while taking POTASSIUM CHLORIDE FOR ORAL SOLUTION, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.